Core Insights - Merck Animal Health showcased its integrated solutions for animal health at the 2025 China International Import Expo, emphasizing the "One Health" concept [2] - The company aims to enhance local R&D and production capabilities in China, with approximately 50 vaccines and chemical products already launched in the market [2] - The recent launch of two new vaccines for swine, aimed at addressing significant economic diseases in China's pig farming industry, is expected to improve herd health and farming efficiency [3] Group 1 - Merck Animal Health presented a comprehensive portfolio covering companion animals, aquaculture, pigs, poultry, and ruminants, integrating vaccines, pharmaceuticals, and technological solutions [2] - The company operates its China headquarters in Shanghai, with production bases in Ningbo and Tianjin, and a research center in Ningbo [2] - The newly approved vaccines, including the first needle-free intradermal vaccine for porcine circovirus, provide innovative solutions for common diseases affecting the swine industry [2][3] Group 2 - The introduction of the new vaccines is expected to help reduce the high costs associated with pig farming in China, which is the world's largest pork market [3] - The company believes that these solutions will contribute to the stability of pork supply and improve the quality of products available to consumers [3]

Core Insights - The eighth China International Import Expo will be held in Shanghai from November 5 to 10, 2025, with Merck participating for the seventh consecutive time, showcasing its animal health business centered around the "One Health" concept [2] - Merck's animal health division emphasizes innovative products and technologies to enhance industry development and integrates social responsibility into its corporate DNA [2] - The company is presenting two new pig vaccines at the expo, aimed at addressing significant economic diseases in China's pig farming industry [4][5] Company Developments - Merck is showcasing the "Baozhuli® Yuan An Ke®" and "Baozhuli® Yuan Le Da®" vaccines, which are designed to provide new solutions for porcine circovirus and Mycoplasma pneumonia infections [2][4] - The introduction of these vaccines is expected to improve pig herd health and farming efficiency in China, the world's largest pig market [5] - In the companion animal sector, Merck is highlighting its "Chongbiwei®" vaccine series and Sure Petcare's smart pet products, aimed at providing efficient and safe solutions for pet healthcare [5] Industry Context - Porcine circovirus type 2 and Mycoplasma pneumonia are major economic diseases affecting China's pig farming, contributing to high breeding costs [4] - Merck's commitment to public health is demonstrated through its partnership with the China Small Animal Protection Association, having donated over 180,000 doses of rabies vaccines since 2016 [5] - The aquaculture segment is also featured at the expo, with Merck presenting a comprehensive product range following its acquisition of the Blue River Animal Health business, which includes vaccines, dewormers, and nutritional supplements [5]